Skip to main content
Erschienen in: Journal of Neurology 3/2015

01.03.2015 | Letter to the Editors

Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy

verfasst von: Helmar C. Lehmann, Klaus Krüger, Gereon R. Fink, Michael Schroeter

Erschienen in: Journal of Neurology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sirs, …
Literatur
1.
Zurück zum Zitat Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48CrossRefPubMed Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48CrossRefPubMed
2.
Zurück zum Zitat Happe S, Husstedt IW (2000) Successful treatment of acute encephalomyelitis associated with common variable immunodeficiency syndrome (CVID): case report and review of the literature. J Neurol 247:562–565CrossRefPubMed Happe S, Husstedt IW (2000) Successful treatment of acute encephalomyelitis associated with common variable immunodeficiency syndrome (CVID): case report and review of the literature. J Neurol 247:562–565CrossRefPubMed
3.
Zurück zum Zitat Narula S, LaRosa DF, Kamoun M, Dalmau J, Levinson AI (2007) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol 98:483–489CrossRefPubMed Narula S, LaRosa DF, Kamoun M, Dalmau J, Levinson AI (2007) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol 98:483–489CrossRefPubMed
4.
Zurück zum Zitat Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS (2008) Common variable immunodeficiency: a new look at an old disease. Lancet 372:489–502CrossRefPubMed Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS (2008) Common variable immunodeficiency: a new look at an old disease. Lancet 372:489–502CrossRefPubMed
5.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302PubMedCentralCrossRefPubMed Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Rieckmann P, Heidenreich F, Sailer M, Zettl UK, Zessack N, Hartung HP, Gold R (2012) Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis. Ther Adv Neurol Disord 5:3–12PubMedCentralCrossRefPubMed Rieckmann P, Heidenreich F, Sailer M, Zettl UK, Zessack N, Hartung HP, Gold R (2012) Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis. Ther Adv Neurol Disord 5:3–12PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Rudge P, Webster AD, Revesz T, Warner T, Espanol T, Cunningham-Rundles C, Hyman N (1996) Encephalomyelitis in primary hypogammaglobulinemia. Brain 119(Pt 1):1–15CrossRefPubMed Rudge P, Webster AD, Revesz T, Warner T, Espanol T, Cunningham-Rundles C, Hyman N (1996) Encephalomyelitis in primary hypogammaglobulinemia. Brain 119(Pt 1):1–15CrossRefPubMed
8.
Zurück zum Zitat Scotton PG, Vaglia A, Carniato A, Marchiori GC (1998) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency. Clin Infect Dis 26:215–216CrossRefPubMed Scotton PG, Vaglia A, Carniato A, Marchiori GC (1998) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency. Clin Infect Dis 26:215–216CrossRefPubMed
9.
Zurück zum Zitat Snyder MD, Storch GA, Clifford DB (2005) Atypical PML leading to a diagnosis of common variable immunodeficiency. Neurology 64:1661CrossRefPubMed Snyder MD, Storch GA, Clifford DB (2005) Atypical PML leading to a diagnosis of common variable immunodeficiency. Neurology 64:1661CrossRefPubMed
10.
Zurück zum Zitat Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F (2013) The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler 19:1826–1840CrossRefPubMed Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F (2013) The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler 19:1826–1840CrossRefPubMed
11.
Zurück zum Zitat Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075–1080CrossRefPubMed Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075–1080CrossRefPubMed
Metadaten
Titel
Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy
verfasst von
Helmar C. Lehmann
Klaus Krüger
Gereon R. Fink
Michael Schroeter
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 3/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7620-4

Weitere Artikel der Ausgabe 3/2015

Journal of Neurology 3/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.